Concentrations of Risk |
12 Months Ended |
|---|---|
Jun. 28, 2026 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations of Risk | Concentrations of Risk Financial instruments, which may subject the Company to a concentration of risk, consist principally of short-term investments, cash equivalents, accounts receivable and long-term receivables. Short-term investments consist primarily of municipal bonds, corporate bonds, U.S. agency securities, U.S. treasury securities, commercial paper and certificates of deposit. The Company’s cash equivalents consist primarily of money market funds. Certain bank deposits may at times be in excess of the FDIC insurance limits. The Company sells its products on account to manufacturers, distributors and others worldwide and generally requires no collateral. For the period from June 30, 2025 to September 29, 2025, two customers represented 13% and 28% of revenue, respectively. For the period from September 30, 2025 to June 28, 2026, two customers represented 11% and 27% of revenue, respectively. For the fiscal year ended June 29, 2025, two customers represented 19% and 18% of revenue, respectively. For the fiscal year ended June 30, 2024, two customers represented 13% and 24% of revenue, respectively. No other customers individually accounted for more than 10% of revenue for the periods from June 30, 2025 to September 29, 2025 and from September 30, 2025 to June 28, 2026 and the fiscal years ended June 29, 2025 and June 30, 2024. Two customers accounted for 15% and 11% of the accounts receivable balance as of June 28, 2026, respectively. Two customers accounted for 26% and 12% of the accounts receivable balance as of June 29, 2025, respectively. No other customers accounted for more than 10% of the accounts receivable balance as of June 28, 2026 and June 29, 2025.
|